The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial.
 
Wael Hozaeel
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Nils Homann
No Relationships to Disclose
 
Kim Luley
No Relationships to Disclose
 
Thomas Werner Kraus
No Relationships to Disclose
 
Jorg Trojan
No Relationships to Disclose
 
Wolf O. Bechstein
No Relationships to Disclose
 
Kersten Grimm
No Relationships to Disclose
 
Bettina Heise
No Relationships to Disclose
 
Wolff Schmiegel
No Relationships to Disclose
 
Daniel Pink
No Relationships to Disclose
 
Salah-Eddin Al-Batran
No Relationships to Disclose